| 322648-50-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 糖脂
• CAS: 322648-50-0
• 化学式: C₈₄H₉₉NO₂₃SSi
• 分子量: 1550.85
• InChiKey: KZWUPEUJQAWHKN-ISSOUADZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  11.55
• 重原子数：
  110.0
• 可旋转键数：
  40.0
• 环数：
  12.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  274.52
• 氢给体数：
  2.0
• 氢受体数：
  23.0

反应信息

• 作为反应物：
  描述：

  在 吡啶 、 溶剂黄146 、 肼 作用下， 以87%的产率得到
  参考文献：
  名称：

  Total Syntheses of Tumor-Related Antigens N3:  Probing the Feasibility Limits of the Glycal Assembly Method

  摘要：

  The total syntheses of two octasaccharide antigens isolated from human milk, 1 and 2, and their corresponding allyl glycosides, 3 and 4, have been achieved by utilizing the glycal method, Convergent assembly of the core hexasaccharides and concurrent introduction of two alpha -L-fucosyl moieties at the late stage of the syntheses provided these complex:carbohydrates in a concise manner. With synthetic material obtained, biological evaluations of these antigens as potential gastrointestinal cancer immunotherapeutic agents have been initiated.

  DOI：

  10.1021/ja0022730
• 作为产物：
  描述：

  4-Oxo-pentanoic acid (2R,3R,4S,5R,6S)-5-benzyloxy-6-((2R,3S,4R)-4-benzyloxy-2-benzyloxymethyl-3,4-dihydro-2H-pyran-3-yloxy)-3,4-dihydroxy-tetrahydro-pyran-2-ylmethyl ester 、 N-[(2S,3R,4R,5R,6R)-5-[[(3aS,4R,6S,7R,7aS)-2-oxo-7-phenylmethoxy-4-(phenylmethoxymethyl)-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-yl]oxy]-2-ethylsulfanyl-6-(phenylmethoxymethyl)-4-triethylsilyloxyoxan-3-yl]benzenesulfonamide 在 Di-tert-butylpyridine 、 三氟甲烷磺酸甲酯 、 三乙胺 作用下， 以 乙醚 、 二氯甲烷 为溶剂， 反应 6.34h， 以70%的产率得到
  参考文献：
  名称：

  Total Syntheses of Tumor-Related Antigens N3:  Probing the Feasibility Limits of the Glycal Assembly Method

  摘要：

  The total syntheses of two octasaccharide antigens isolated from human milk, 1 and 2, and their corresponding allyl glycosides, 3 and 4, have been achieved by utilizing the glycal method, Convergent assembly of the core hexasaccharides and concurrent introduction of two alpha -L-fucosyl moieties at the late stage of the syntheses provided these complex:carbohydrates in a concise manner. With synthetic material obtained, biological evaluations of these antigens as potential gastrointestinal cancer immunotherapeutic agents have been initiated.

  DOI：

  10.1021/ja0022730